Sfoglia per Corso Innovation in immuno-mediated and hematological disorders
Analysis of T cell response in bladder cancer patients treated with Bacillus of Calmette-Guérin (BCG)
2024
Analysis of the mechanisms regulating human ILC2 activation and function
2025
Anti-β2glycoprotein i-induced neutrophil extracellular traps cause endothelial activation
2026
Characterization of non-driver mutations and identification of different outcomes and treatment strategies based on NGS results in myelofibrosis patients in different clinical stages
2023
Characterization of the role of CCRL2 in lung and intestine immune surveillance
2024
Crucial role of CXCL4 and type I interferon in early Systemic sclerosis: ways to block them via new pharmacological intervention by drug repositioning (Hydroxychloroquine) and experimental small molecules
2026
Deconstructing the molecular programs of natural killer cells to identify novel targets in intestinal inflammation
2026
Defining the role of myeloid populations in lupus nephritis: a spatially resolved multi-omics approach
2025
Development of GD2- and FAP- targeted CAR T-cell strategies to overcome tumor and stroma barriers in osteosarcoma
2026
Donor specific anti-HLA antibodies in Hematopoietic Stem Cell Transplantation. A stepwise project to establish a better definition of their role and a desensitization strategy
2021
Effect of TRPV receptor agonists in chronic myeloid leukemia
2022
Exploiting the therapeutic potential of ADAR1 silencing to enhance NK cell-mediated responses against cervical cancer
2026
Exploring the interplay between the RNA editing enzyme ADAR1 and innate immune responses in cervical cancer
2025
EZH2 gene mutations and copy number variation as prognostic markers in advanced follicular lymphoma
2025
Gene expression of monocytes and targeted protein biomarker assessment in patients with polymyalgia rheumatica
2026
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: an italian multicenter retrospective study
2025
Harnessing the cGAS-STING-IFN-λ signaling to reprogram the immunosuppressive niche of Multiple Myeloma and potentiate NK cell–mediated tumor control
2026
Identification and characterization of circulating mesenchymal stem cells: novel prospects for cell-based therapy in erosive hand osteoarthritis
2025
Immune profile of cancer patients to improve selection and efficacy of immunotherapeutic strategies
2022
Immunostimulatory activity and regulation of extracellular 2’3’-cGAMP in human multiple myeloma
2022
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile